Optical theranostics in ischemic heart disease: from molecular insights to clinical translation
Theranostics · 09.06.2025 · 15 (14) · 6789-6817
DOI: 10.7150/thno.114307 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Theranostics, erschienen am 09.06.2025. Verfasst von Yangjie Xiao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ultrasound, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004 Liaoning, China. Hauptthemen laut MEDLINE: Myocardial Ischemia, Theranostic Nanomedicine, Optical Imaging. Die Arbeit wurde bisher 3-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Accurate risk stratification of ischemic heart disease (IHD) remains pivotal for mitigating associated global health burdens. Optical theranostics, combining imaging and therapeutic capabilities through light-based technologies, has emerged as a transformative strategy for IHD management. Advanced modalities mainly including optical coherence tomography, near-infrared fluorescence imaging, and photoacoustic imaging enable high-resolution visualization of coronary anatomy, myocardial perfusion, and molecular biomarkers. These modalities complement traditional cardiovascular imaging by providing real-time functional and molecular data with enhanced spatial resolution. Concurrently, phototherapy strategies such as image-guided photodynamic and photothermal therapies show therapeutic potential in preclinical studies. Integrated theranostic platforms now operationalize closed-loop workflows, where diagnostic imaging directly informs therapeutic parameters and monitors treatment response. While challenges persist in clinical translation-including tissue penetration limitations and safety optimization-ongoing developments in contrast agents, device miniaturization, and multimodal integration are accelerating practical applications. This review examines current progress in optical theranostics for IHD, analyzing technical principles, preclinical/clinical implementations, and translational barriers to optimize cardiovascular care through light-based technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ultrasound, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004 Liaoning, China.
- Department of Cardiac Surgery, Shengjing Hospital of China Medical University, No. 36 Sanhao Street, Heping District, Shenyang, 110004 Liaoning, China.
Zitieren
APA
Xiao, Y., Zhang, J., Sun, L., Wang, K., Chen, Y., Zheng, Q., & Li, Y. (2025). Optical theranostics in ischemic heart disease: from molecular insights to clinical translation. Theranostics, 15(14), 6789-6817. https://doi.org/10.7150/thno.114307
Vancouver
Xiao Y, Zhang J, Sun L, Wang K, Chen Y, Zheng Q, et al. Optical theranostics in ischemic heart disease: from molecular insights to clinical translation. Theranostics. 2025;15(14):6789-6817. doi:10.7150/thno.114307
BibTeX
@article{Xiao2025,
author = {Xiao, Yangjie and Zhang, Jing and Sun, Lu and Wang, Ke and Chen, Yan and Zheng, Qiaojin and Li, Ying},
title = {Optical theranostics in ischemic heart disease: from molecular insights to clinical translation},
journal = {Theranostics},
year = {2025},
volume = {15},
number = {14},
pages = {6789--6817},
doi = {10.7150/thno.114307}
}
EUVIMED